|
|
Blood, 1 November 2003, Vol. 102, No. 9, pp. 3302-3310.
Prepublished online as a Blood First Edition Paper on July 17, 2003; DOI 10.1182/blood-2003-02-0384.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors
A. Karolina Palucka,
Joel Gatlin,
Jean Philippe Blanck,
Michael W. Melkus,
Sandra Clayton,
Hideki Ueno,
Elizabeth T. Kraus,
Petra Cravens,
Lynda Bennett,
Angela Padgett-Thomas,
Florentina Marches,
Miguel Islas-Ohlmayer,
J. Victor Garcia, and
Jacques Banchereau
From the Baylor Institute for Immunology Research and University of Texas Southwestern Medical Center, Dallas.
Distinct human dendritic cell (DC) subsets differentially control immunity. Thus, insights into their in vivo functions are important to understand the launching and modulation of immune responses. We show that nonobese diabetic/LtSz-scid/scid (NOD/SCID) mice engrafted with human CD34+ hematopoietic progenitors develop human myeloid and plasmacytoid DCs. The skin displays immature DCs expressing Langerin, while other tissues display interstitial DCs. Myeloid DCs from these mice induce proliferation of allogeneic CD4 T cells in vitro, and bone marrow human cells containing plasmacytoid DCs release interferon- (IFN-) upon influenza virus exposure. Injection of influenza virus into reconstituted mice triggers IFN- release and maturation of mDCs. Thus, these mice may provide a model to study the pathophysiology of human DC subsets.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
F. Ishikawa, H. Niiro, T. Iino, S. Yoshida, N. Saito, S. Onohara, T. Miyamoto, H. Minagawa, S.-i. Fujii, L. D. Shultz, et al.
The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways
Blood,
November 15, 2007;
110(10):
3591 - 3660.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Aspord, A. Pedroza-Gonzalez, M. Gallegos, S. Tindle, E. C. Burton, D. Su, F. Marches, J. Banchereau, and A. K. Palucka
Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development
J. Exp. Med.,
May 14, 2007;
204(5):
1037 - 1047.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Abbasian, D. Mahmud, N. Mahmud, S. Chunduri, H. Araki, P. Reddy, R. Hoffman, M. Arpinati, J. L. M. Ferrara, and D. Rondelli
Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting function
Blood,
July 1, 2006;
108(1):
203 - 208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Macchiarini, M. G. Manz, A. K. Palucka, and L. D. Shultz
Humanized mice: are we there yet?
J. Exp. Med.,
November 21, 2005;
202(10):
1307 - 1311.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Bente, M. W. Melkus, J. V. Garcia, and R. Rico-Hesse
Dengue Fever in Humanized NOD/SCID Mice
J. Virol.,
November 1, 2005;
79(21):
13797 - 13799.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. Cravens, M. W. Melkus, A. Padgett-Thomas, M. Islas-Ohlmayer, M. del P. Martin, and J. V. Garcia
Development and Activation of Human Dendritic Cells In Vivo in a Xenograft Model of Human Hematopoiesis
Stem Cells,
February 1, 2005;
23(2):
264 - 278.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Traggiai, L. Chicha, L. Mazzucchelli, L. Bronz, J.-C. Piffaretti, A. Lanzavecchia, and M. G. Manz
Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice
Science,
April 2, 2004;
304(5667):
104 - 107.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D.-W. Kim, Y.-J. Chung, T.-G. Kim, Y.-L. Kim, and I.-H. Oh
Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation
Blood,
March 1, 2004;
103(5):
1941 - 1948.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
